ConductScience.org, home

Paper38005286

HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.

Yang B and 6 others. Molecules, 2023. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44. Papers, record 38005286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38005286

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HA-Coated PLGA Nanoparticles Loaded with Apigenin for Colon Cancer with High Expression of CD44.
PubMed
Journal
Molecules
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
2.61
iCite
Revised in PubMed
2023-11-27
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Yang BBo
2Mao YYongqing
3Zhang YYanjun
4Hao YYue
5Guo MMeitong
6Li BBian
7Peng HHaisheng

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NanoparticlesMajor topic
Colonic NeoplasmsMajor topic
Animals
Mice
Hyaluronic Acid
Apigenin
Mice, Nude
Drug Carriers
Cell Line, Tumor

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2020CX41Harbin University of Commerce Youth Top Talent ProgramPubMed

Source PubMed

Download CSV of grants

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133970845Effect of Modifications in Poly (Lactide-co-Glycolide) (PLGA) on Drug Release and Degradation Characteristics: A Mini Review.Curr Drug Deliv2021https://conductscience.org/library/papers/33970845PubMed
235216149PLGA-Based Composites for Various Biomedical Applications.Int J Mol Sci2022https://conductscience.org/library/papers/35216149PubMed
330875872The Therapeutic Potential of Apigenin.Int J Mol Sci2019https://conductscience.org/library/papers/30875872PubMed
437655476Multifunctional GQDs for receptor targeting, drug delivery, and bioimaging in pancreatic cancer.Nanoscale2023https://conductscience.org/library/papers/37655476PubMed
535998830Apigenin and its dermatological applications: A comprehensive review.Phytochemistry2022https://conductscience.org/library/papers/35998830PubMed
634184949PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application.Drug Deliv2021https://conductscience.org/library/papers/34184949PubMed
729680738Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.Biomed Pharmacother2018https://conductscience.org/library/papers/29680738PubMed
832517278Hyaluronic Acid and Controlled Release: A Review.Molecules2020https://conductscience.org/library/papers/32517278PubMed
916640493Nanoparticle-aptamer bioconjugates for cancer targeting.Expert Opin Drug Deliv2006https://conductscience.org/library/papers/16640493PubMed
1022584163α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug.ACS Nano2012https://conductscience.org/library/papers/22584163PubMed
1135752426Apigenin in cancer prevention and therapy: A systematic review and meta-analysis of animal models.Crit Rev Oncol Hematol2022https://conductscience.org/library/papers/35752426PubMed
1235164326Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells.Molecules2022https://conductscience.org/library/papers/35164326PubMed
1329116098Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.Sci Rep2017https://conductscience.org/library/papers/29116098PubMed
1427919215Current Strategies in the Modification of PLGA-based Gene Delivery System.Curr Med Chem2017https://conductscience.org/library/papers/27919215PubMed
1526961463Cellular distribution of injected PLGA-nanoparticles in the liver.Nanomedicine2016https://conductscience.org/library/papers/26961463PubMed
1629554416Hyaluronic Acid/Chitosan Coacervate-Based Scaffolds.Biomacromolecules2018https://conductscience.org/library/papers/29554416PubMed
1727766890Pharmacokinetic properties and drug interactions of apigenin, a natural flavone.Expert Opin Drug Metab Toxicol2017https://conductscience.org/library/papers/27766890PubMed
1833683499Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery.AAPS PharmSciTech2021https://conductscience.org/library/papers/33683499PubMed
1926453158Hyaluronic acid targeting of CD44 for cancer therapy: from receptor biology to nanomedicine.J Drug Target2015https://conductscience.org/library/papers/26453158PubMed
2029097249Apigenin: A dietary flavonoid with diverse anticancer properties.Cancer Lett2018https://conductscience.org/library/papers/29097249PubMed

See all 34 referencesDownload CSV of references

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42936725Bioactive Polysaccharide-Phytochemical Supramolecular Co-Assemblies for Carrier-Free and Carrier-Minimized Nanomedicine: Design Principles and Translational Challenges.Int J Nanomedicine2026https://conductscience.org/library/papers/42936725PubMed
42675095Nanoparticle-enhanced apigenin suppresses androgen receptor signaling and cellular plasticity in LNCaP cells.Sci Rep2026https://conductscience.org/library/papers/42675095PubMed
42524089Apigenin as a Multi-Targeted Agent in Gastrointestinal Cancers: A Systems Pharmacology Approach.Adv Pharm Bull2026https://conductscience.org/library/papers/42524089PubMed
42365116Unveiling the potential of solid lipid nanoparticles of apigenin-Cu(II) coordinated nanocomplex in colon cancer.Naunyn Schmiedebergs Arch Pharmacol2026https://conductscience.org/library/papers/42365116PubMed
41939211Natural Polymers Based Biocompatible Nanomedicines for Targeting Colon Cancer: Prospects and Challenges.Int J Nanomedicine2026https://conductscience.org/library/papers/41939211PubMed
41440901Chitosan-Based Drug Delivery Systems for Targeted Chemotherapy in Colorectal Cancer: A Scoping Review.Mar Drugs2025https://conductscience.org/library/papers/41440901PubMed
40859950Combined Hyaluronic Acid Nanobioconjugates Impair CD44-Signaling for Effective Treatment Against Obesity: A Review of Comparison with Other Actors.Int J Nanomedicine2025https://conductscience.org/library/papers/40859950PubMed
40788176Unlocking the full potential of piperine-loaded nanocarriers for cancer treatment.Ther Deliv2025https://conductscience.org/library/papers/40788176PubMed
40561797Targeting drug resistant colorectal cancer with apigenin nanoarchitectures.Transl Oncol2025https://conductscience.org/library/papers/40561797PubMed
40006045Flavonoids and Flavonoid-Based Nanopharmaceuticals as Promising Therapeutic Strategies for Colorectal Cancer-An Updated Literature Review.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/40006045PubMed
39686635An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas.Curr Med Chem2025https://conductscience.org/library/papers/39686635PubMed
39416904Nature's weapons: Bioactive compounds as anti-cancer agents.AIMS Public Health2024https://conductscience.org/library/papers/39416904PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AVPR2554PubTator's text mininghttps://conductscience.org/library/genes/554NCBI Gene
CD44960PubTator's text mininghttps://conductscience.org/library/genes/960NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38005286

GET https://conductscience.org/api/papers/v1/38005286/references?page=2